According to Zhitong Finance App, Jingtai Holdings (02228.HK) announced that LCC Technologies Ltd. (LCC Technologies), a wholly-owned subsidiary of the company, and the Stanford University Board of Governors have signed a drug discovery cooperation agreement. The collaboration combines Stanford University's disease biology research with LCC Technologies' automated and AI-driven small molecule drug discovery platform to accelerate and drive the development of new drugs.

According to Zhitong Finance App, Jingtai Holdings (02228.HK) announced that LCC Technologies Ltd. (LCC Technologies), a wholly-owned subsidiary of the company, and the Stanford University Board of Governors have signed a drug discovery cooperation agreement. The collaboration combines Stanford University's disease biology research with LCC Technologies' automated and AI-driven small molecule drug discovery platform to accelerate and drive the development of new drugs.